Delivery Order SPE2DB22D3501-SPE2DB25FUZ78
Award Date
3/21/25
Potential Completion Date
3/24/25
Potential Value
$2.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Leuprolide 2WK 14 MG/2.8 ML kits, a specialty medication. The contract has a ceiling value of $3,923.83 and an ultimate completion date of October 27, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LEUPROLIDE 2WK 14 MG/2.8 ML KTS, a specialty medication, with a ceiling value of $3,570.36 and a period of performance through February 25, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,065.38, is for the delivery of LEUPROLIDE 2WK 14 MG/2.8 ML KTS, a pharmaceutical product. The contract has a period of performance ending on March 24, 2025 and is a firm fixed-price contract. AmerisourceBergen Drug Corp is a for-profit organization and has no set-aside...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the medication Leuprolide 2WK 14 MG/2.8 ML KTS. The contract has a ceiling value of $69,876.47 and is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999 through December 2025. The contract is for a Firm Fixed Price and is not set aside for any specific business type....
This federal contract award, valued at $1,829.02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of leuprolide 2-week kits, a specialty medication, to support military healthcare programs. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This federal contract award, valued at $8,365.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for the provision of Leuprolide 2-week, 14 mg/2.8 ml kits, a specialty medication. The contract is a firm fixed-price delivery order that supports the DLA Troop Support Medical program, which provides essential pharmaceutical and medical supplies to military...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Lupron Depot 11.25 mg 3-month kits. The contract has a ceiling value of $8,621.61 and runs through January 31, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $8,251.47, is for the delivery of Leuprolide 2WK 14 MG/2.8 ML Kits, a specialty pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 21, 2023. This award is part of a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of LUPRON DEPOT 45 MG 6MO KITS. The contract has a ceiling value of $4,458.35 and will run through January 2, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lupron Depot 22.5 mg 3-month kits. The contract has a firm fixed price of $2,755.72 and a period of performance through April 17, 2025. The contract is not set aside and is considered an open competition award. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...